Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-02-13
1990-09-11
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548253, A61K 3141, C07D25704
Patent
active
049563769
ABSTRACT:
Heterocyclic acids and esters useful as inhibitors of mammalian blood platelet aggregation characterized by Formula I or II are disclosed. ##STR1## Formula I compounds are those wherein n is 6-9, R is hydrogen, lower alkyl or an alkali metal ion, and HET.sub.1 is the heterocyclic radical 5-(diphenylmethyl)-2H-tetrazol-2-yl.
REFERENCES:
patent: 3453285 (1969-07-01), Hayao
patent: 3962272 (1976-06-01), Katner
patent: 4059703 (1977-11-01), Burrell et al.
patent: 4652671 (1987-03-01), Bison et al.
patent: 4755518 (1988-07-01), Rafferty et al.
Bristol--Myers Squibb Company
Springer David B.
Uloth Robert H.
LandOfFree
Tetrazole carboxylic acids and esters and inhibition of blood pl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrazole carboxylic acids and esters and inhibition of blood pl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrazole carboxylic acids and esters and inhibition of blood pl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1185062